Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021

SELL
$7.2 - $16.82 $175,665 - $410,374
-24,398 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$5.77 - $11.33 $37,753 - $74,132
6,543 Added 36.65%
24,398 $222,000
Q3 2020

Nov 16, 2020

BUY
$5.09 - $11.07 $14,307 - $31,117
2,811 Added 18.69%
17,855 $198,000
Q2 2020

Aug 14, 2020

BUY
$4.62 - $8.01 $69,503 - $120,502
15,044 New
15,044 $112,000

Others Institutions Holding KLDO

About Kaleido Biosciences, Inc.


  • Ticker KLDO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,622,600
  • Description
  • Kaleido Biosciences, Inc., a clinical-stage healthcare company, develops microbiome metabolic therapies. The company develops KB195 for the treatment of patients with urea cycle disorder; KB295 to treat ulcerative colitis; KB174 for the treatment of hepatic encephalopathy; and KB109 to treat COVID-19 disease. It also develops programs for the tr...
More about KLDO
Track This Portfolio

Track Susquehanna Fundamental Investments, LLC Portfolio

Follow Susquehanna Fundamental Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.